Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

VI.e

Fat/oil embolism - The FES embolism syndrome

Publications

Wu GC, Chan ED, Chou YC, Yu CY, Hsieh TY, Hsieh CB, Chian CF, Ke FC, Dai YL, Su WL

Risk factors for the development of pulmonary oil embolism after transcatheter arterial chemoembolization of hepatic tumors.

Anti-cancer drugs. 2014;25(8):976-81

Bánsághi Z, Kaposi PN, Lovas G, Szentmártoni G, Várallyay G, Bata P, Kalina I, Futácsi B, Bérczi V

Cerebral iodized lipid embolization via a pulmonary arteriovenous shunt: rare complication of transcatheter arterial embolization for hepatocellular carcinoma.

World journal of surgical oncology. 2013;11:122

Czauderna P, Zbrzezniak G, Narozanski W, Sznurkowska K, Skoczylas-Stoba B, Stoba C

Pulmonary embolism: a fatal complication of arterial chemoembolization for advanced hepatocellular carcinoma.

Journal of pediatric surgery. 2005;40(10):1647-50

Chung JW, Park JH, Han JK, Choi BI, Han MC, Lee HS, Kim CY

Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization.

Radiology. 1996;198(1):33-40

Chung JW, Park JH, Im JG, Han JK, Han MC

Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma.

Radiology. 1993;187(3):689-93